Abstract
Background
The retropancreatic space between the superior mesenteric artery, celiac axis, and portal vein is called the mesopancreas. Total mesopancreas excision and skeletonization of both celiac axis and superior mesenteric artery are used to reduce R1 resection in high-risk patients and in those with locally advanced disease. The aim of this study was to present a series of video clips from several patients showing the mesopancreas excision and the triangle operation with a detailed technical description of both techniques with different approaches.
Methods
Video clips were compiled from several robotic pancreatoduodenectomies to demonstrate the total mesopancreas excision and triangle operation technique, as follows: (1) main steps for mesopancreas excision and triangle operation, (2) anterior approach for mesopancreas excision, and (3) triangle operation.
Results
A total of 87 patients underwent robotic PD at our center between March 2018 and March 2021. Of these, 22 patients underwent robotic mesopancreas excision. This technique was used for patients at high risk for R1 resection in 18 patients and triangle operation in four patients. Partial portal vein resection was necessary in 6 cases. One patient had R1 resection and was treated with adjuvant therapy. The remaining patients presented free surgical margins. The mean number of harvested lymph nodes was 40 (range: 27–77). The median interval between the operation and chemotherapy was 23 days.
Conclusions
The robotic total mesopancreas excision and the triangle operation are feasible and safe for selected patients. The indication for this radical operation is the presence of a high risk for R1 resection and for those with locally advanced disease. The presented video may help oncological surgeons to perform these techniques.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Crippa S, Giannone F, Schiavo Lena M, Belfiori G, Partelli S, Tamburrino D, Delpini R, Pagnanelli M, Pecorelli N, Balzano G, Doglioni C, Falconi M. R status is a relevant prognostic factor for recurrence and survival after pancreatic head resection for ductal adenocarcinoma. Ann Surg Oncol. 2021. https://doi.org/10.1245/s10434-020-09467-6.
Dillhoff M, Pawlik TM. Role of node dissection in pancreatic tumor resection. Ann Surg Oncol. 2021;28(4):2374–81.
Mu DQ, Peng SY, Wang GF. Risk factors influencing recurrence following resection of pancreatic head cancer. World J Gastroenterol. 2004;10(6):906–9.
Gaedcke J, Gunawan B, Grade M, Szöke R, Liersch T, Becker H, Ghadimi BM. The mesopancreas is the primary site for R1 resection in pancreatic head cancer: relevance for clinical trials. Langenbecks Arch Surg. 2010;395(4):451–8.
Adham M, Singhirunnusorn J. Surgical technique and results of total mesopancreas excision (TMpE) in pancreatic tumors. Eur J Surg Oncol. 2012;38(4):340–5. https://doi.org/10.1016/j.ejso.2011.12.015.
Leach SD, Davidson BS, Ames FC, Evans DB. Alternative method for exposure of the retropancreatic mesenteric vasculature during total pancreatectomy. J Surg Oncol. 1996;61(2):163–5.
Machado MC, Penteado S, Cunha JE, Jukemura J, Herman P, Bacchella T, Machado MA, Montagnini AL. Pancreatic head tumors with portal vein involvement: an alternative surgical approach. Hepatogastroenterology. 2001;48(41):1486–7.
Hackert T, Strobel O, Michalski CW, Mihaljevic AL, Mehrabi A, Müller-Stich B, Berchtold C, Ulrich A, Büchler MW. The TRIANGLE operation - radical surgery after neoadjuvant treatment for advanced pancreatic cancer: a single arm observational study. HPB (Oxford). 2017;19(11):1001–7.
Kendrick ML, van Hilst J, Boggi U, et al. Minimally invasive pancreatoduodenectomy. HPB (Oxford). 2017;19:215–24.
Machado MA, Surjan RC, Basseres T, et al. Laparoscopic pancreatoduodenectomy in 50 consecutive patients with no mortality: a single-center experience. J Laparoendosc Adv Surg Tech A. 2016;26:630–4.
Torphy RJ, Friedman C, Halpern A, et al. Comparing short-term and oncologic outcomes of minimally invasive versus open pancreaticoduodenectomy across low and high volume centers. Ann Surg. 2018. https://doi.org/10.1097/SLA.0000000000002810.
Machado MA, Mattos BV, Lobo Filho MM, Makdissi FF. Robotic artery-first approach during pancreatoduodenectomy. Ann Surg Oncol. 2021. https://doi.org/10.1245/s10434-021-09776-4.
Croome KP, Farnell MB, Que FG, Reid-Lombardo KM, Truty MJ, Nagorney DM, Kendrick ML. Total laparoscopic pancreaticoduodenectomy for pancreatic ductal adenocarcinoma: oncologic advantages over open approaches? Ann Surg. 2014;260(4):633–8.
Machado MA, Lobo Filho MM, Mattos BH, Ardengh JC, Makdissi FF. Robotic pancreatic resection Personal experience with cases. Rev Col Bras Cir. 2020;47:e20202501.
Machado MA, Surjan R, Bassères T, Ardengh A, Makdissi F. Robotic pancreaticoduodenectomy after Roux-en-Y gastric bypass. Surg Oncol. 2019;29:118–9.
Machado MA, Surjan R, Makdissi F, Ardengh JC. Robotic pancreaticoduodenectomy after unsuspected double perforation (bile duct and portal vein) during endoscopic biliary stent placement. Surg Oncol. 2020;34:195–6.
Rosso E, Zimmitti G, Iannelli A, Garatti M. The “TRIANGLE Operation” by Laparoscopy: Radical Pancreaticoduodenectomy with Major Vascular Resection for Borderline Resectable Pancreatic Head Cancer. Ann Surg Oncol. 2020;27(5):1613–4.
Author information
Authors and Affiliations
Corresponding author
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Supplementary file1 (MOV 229691 kb)
Rights and permissions
About this article
Cite this article
Machado, M.A., Mattos, B.V., Lobo Filho, M.M. et al. Mesopancreas Excision and Triangle Operation During Robotic Pancreatoduodenectomy. Ann Surg Oncol 28, 8330–8334 (2021). https://doi.org/10.1245/s10434-021-10412-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1245/s10434-021-10412-4